Résultats de la recherche - 5 results
Variation in smoking attributable all-cause mortality across municipalities in Belgium, 2018: application of a Bayesian approach for small area estimations
worldwide, with the European Region having the highest prevalence of tobacco smoking among adults compared to other WHO regions. The Belgian Health Interview Survey (BHIS) provides a reliable source of ...
COVID-19 and people who use drugs: Impact of the pandemic on general anxiety and depressive disorders among adults in Belgium.
previous pandemics people who use drugs (PWUD) were categorized among the most vulnerable. In the current study, firstly, we wanted to evaluate the impact of the COVID-19 crisis on the prevalence of anxiety ...
Women's views on barriers and facilitators for seeking alcohol and drug treatment in Belgium.
interviews were conducted with 60 female substance users who utilise(d) outpatient and/or residential treatment services. A content analysis was performed on women’s personal accounts of previous treatment ...
Understanding New Psychoactive Substance (NPS) use in Belgium from a health perspective (NPS-Care)
Besides the issuing of alerts that involve the use of NPS in the context of European and national Early Warning Systems (EWS), many questions remain. Who uses NPS? How and to which degree? Why? Which ...
The European Web Survey on Drugs: patterns of use of new psychoactive substances in Belgium
and the number of people in the sample who have used substances other than cannabis is too low to permit further analyses. To provide in additional information on the patterns of use, EMCDDA ’s European ...